Intended for infants born to hepatitis B (HBV) infected women to assess infant’s response to initial vaccination and/or enable early detection of HBV infection.
Qualitative Chemiluminescent Immunoassay/Quantitative Chemiluminescent Immunoassay
Within 24 hours
Serum Separator Tube (SST). Also acceptable: Lavender (EDTA) or Pink (K2EDTA).
Separate from cells ASAP or within 2 hours of collection. Transfer 3 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 1.5 mL)
Heparinized plasma. Specimens containing particulate material. Heat-inactivated, severely hemolyzed or lipemic specimens.
After separation from cells: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)
|0020090||Hepatitis B Virus Surface Antibody||
|0020089||Hepatitis B Virus Surface Antigen with Reflex to Confirmation||
This panel of assays should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).
Performed and Reported times indicated are for screening of Hepatitis B Surface Ag w/ Reflex to Conf and Hepatitis B Virus Surface Antibody. If results for Hepatitis B Surface Ag w/ Reflex to Conf screen is repeatedly reactive with an index value between 1.00 and 50.00, then Hepatitis B Virus Surface Ag, Confirm will be added. Additional charges apply.
86317; 87340; if reflexed, add 87341
|Component Test Code*||Component Chart Name||LOINC|
|0020089||Hepatitis B Surface Antigen||5196-1|
|0020090||Hepatitis B Surface Antibody||5193-8|
|2014286||Hepatitis B Panel Interp||48767-8|
- HBsAg screen
- HBV Surface Antigen
- Hep B Surface Antigen
- Hepatitis B PVST Panel
- Hepatitis Bs Ag
- PVST for infants born to HBV-infected mothers, HBV Panel
- PVST Panel, Postvaccination Serologic Testing of Infants Born to Hepatitis B-infected Mothers